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Abstract
Motility of normal and transformed cells within and across tissues requires specialized subcellular structures, e.g. membrane
ruffles, lamellipodia and podosomes, which are generated by dynamic rearrangements of the actin cytoskeleton. Because
the formation of these sub-cellular structures is complex and relatively poorly understood, we evaluated the role of the
adapter protein SH3PXD2B [HOFI, fad49, Tks4], which plays a role in the development of the eye, skeleton and adipose
tissue. Surprisingly, we find that SH3PXD2B is requisite for the development of EGF-induced membrane ruffles and
lamellipodia, as well as for efficient cellular attachment and spreading of HeLa cells. Furthermore, SH3PXD2B is present in a
complex with the non-receptor protein tyrosine kinase Src, phosphorylated by Src, which is consistent with SH3PXD2B
accumulating in Src-induced podosomes. Furthermore, SH3PXD2B closely follows the subcellular relocalization of cortactin
to Src-induced podosomes, EGF-induced membrane ruffles and lamellipodia. Because SH3PXD2B also forms a complex with
the C-terminal region of cortactin, we propose that SH3PXD2B is a scaffold protein that plays a key role in regulating the
actin cytoskeleton via Src and cortactin.
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Introduction
Molecular scaffolds are crossroads where parallel signal transduc-
tion pathways of vital cellular functions including cellular attachment
or migration are integrated [1,2,3]. Scaffold proteins usually consist
of multiple domains that can serve independently or cooperatively as
docking sites to recruit the appropriate set of proteins in a temporally
and spatially ordered fashion. The Pleckstrin homology (PH) and
Phox homology (PX) domains bind different phosphoinositides and
are believed to be responsible for anchoring adaptor proteins to
various microdomains of the cell membrane [4]. PX-domains are
frequently found in combination with Src-homology3 (SH3)
domains that bind to proline-rich sequences. Although the molecular
details of interaction between PX-domain and phospoinositides are
well-mapped, the complexity of the in vivo functions of this PX/SH3
protein module is not well understood.
Recently, a distinct member of PX/SH3 protein family, FISH/
Tks5, comprised of FIve SH3 domains and an N-terminal PX-
domain [5], has emerged as a central player of the protein scaffold
regulating podosome formation in Src-transformed fibroblast cells
[6]. FISH appears to be requisite for the organization of
podosomes [7], actin-rich structures which are implicated in the
invasion of tumor cells as well as in the migration of macrophages
or dendritic cells within tissues [8].
In addition to podosomes, there are other organelles that
control motility and invasion. Lamellipodia and filopodia form at
the leading edge of the migrating cell generated by actin
polymerization at the barbed end of the growing filaments
[9,10]. Lamellipodia are shallow protruding structures comprised
of a dense array of branched actin filaments, while filopodia are
rod-like protrusions built from a bundle of actin filaments
[11,12,13]. Lamellipodia and podosomes are enriched in cortactin
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[14,15], a scaffold protein that is a substrate for Src [15]. Cortactin
has been shown to enhance cell migration in transwell systems, as
well as in wound healing assays [16,17,18,19]. Moreover,
migration, generation of persistent lamellipodia, invadopodia
and efficient cell spreading can be inhibited by siRNAs targeting
cortactin [20,21]. However, experiments with cortactin null
murine fibroblasts showed an impairment only in growth factor
induced actin cytoskeleton reorganization and migration, but not
in generation of lamellipodia[22]. Nevertheless, overexpression of
cortactin in multiple types of human tumors e.g. in gastric, liver
and breast cancer suggests that cortactin is a key regulator of these
processes in vivo [23,24,25].
Recently several groups including ours have identified a
homologue of FISH/Tks5 referred to as HOFI/Tks4/fad49.
Subsequently, another name, SH3PXD2B was also assigned to
the protein that for simplicity will be used in this paper. In in vitro
and ex vivo studies the murine ortologue of SH3PXD2B was shown
to play an important role in the formation of functional podosomes
[26], production of reactive oxygen species (ROS) by tumor cells
[27,28] and in the differentiation of white adipose tissue [29]. In two
independent mice models, the absence of SH3PXD2B was found to
profoundly impair normal development causing runted growth,
craniofacial and skeletal abnormalities, hearing impairment,
glaucoma and the virtual absence of white adipose tissue [30,31].
In humans, SH3PXD2B-deficiency is responsible for the develop-
ment of Frank-Ter Haar syndrome (MIM 249420) [30]. Despite its
impact on development and cell physiology, the molecular
machinery operated by SH3PXD2B is poorly understood.
In the present study we characterize the human orthologue of
SH3PXD2B and examine potential mechanisms and functions
that are controlled by SH3PXD2B. We show that SH3PXD2B,
upon activation by growth factors or expression of constitutively
active Src, associates with dynamic assemblies of the actin
cytoskeleton e.g. lamellipodia and podosomes, independent of
lipid binding via its PX-domain. Furthermore, we found
SH3PXD2B in a complex with two central regulators of the actin
cytoskeleton; Src and cortactin. The latter interaction required the
C-terminal part and an intact SH3-domain of cortactin. When
SH3PXD2B was eliminated by RNA interference we detected a
marked impairment in growth factor-induced membrane ruffling
and in the generation of lamellipodia and hence, as our
experiments show, SH3PXD2B plays an important role in cellular
attachment and cell spreading.
Results
Expression of SH3PXD2B in tumor-derived cell lines and
primary cells
Because FISH/Tks5 appeared implicated in malignancies, we
assessed SH3PXD2B expression in tumor-derived cell lines. To this
end we cloned the full-length cDNA encoding human SH3PXD2B
(Genbank, DQ109556, AAZ99795) and raised a polyclonal
antibody directed against the N-terminal region of the protein.
This antibody, which recognized the predicted protein of
approximately 120 kD in a western blotting experiment
(Figure 1A), detected high levels of SH3PXD2B in several human
tumor cell lines e.g. in HeLa, 293T, the acute B-cell leukemia line
REH, the erythroleukemia cell line TF1 and the A2058 melanoma.
(Figure 1A left panel). As it was not found in Jurkat T cells or in
the acute monocytic leukemia cell line THP1, SH3PXD2B
expression appears not essential to maintain continuous cell
proliferation. Importantly, SH3PXD2B expression is not restricted
to tumor-derived cell lines, as primary cells including human
macrophages and human umbilical vein endothelial cells (HUVEC)
also expressed the protein (Figure 1A right panel).
Next, we examined the intracellular localization of SH3PXD2B
in the tumor-derived HeLa cells or in primary cells, e.g. HUVEC
and monocyte-derived macrophages. SH3PXD2B was present in
or adjacent to the plasma membrane and in the perinuclear region
of both transformed and primary cells (Figure 1B–D). Although
perinuclear staining was prominent in HeLa cells and in HUVEC,
SH3PXD2B did not co-localize with either the endosomal marker
transferrin receptor or the Endoplasmic Reticulum(ER)-specific
protein disulfide-isomerase (data not shown).
In membrane ruffles, lamellipodia and podosomes
SH3PXD2B co-localizes with cortactin
Because FISH/Tks5 and SH3PXD2B were required for the
generation of Src-induced podosomes [7,26,32,33] we reasoned
that SH3PXD2B may also play a role in the generation of other
dynamic membrane structures. To test this, we induced the
formation of membrane ruffles and lamellipodia in serum starved
HeLa cells with epidermal growth factor (EGF) (Figure 2A–F).
Under resting conditions SH3PXD2B localized to the cytosol
often in the perinuclear region, whilst staining of the plasma
membrane appeared to be minimal (Figure 2A). EGF-induced
membrane ruffles and lamellipodia, however, were enriched in
SH3PXD2B (Figure 2D). When cortactin, a marker for cortical
actin polymerization was visualized with a specific antibody, we
observed intense cortactin accumulation in the EGF-induced
membrane protrusions where cortactin co-localized with
SH3PXD2B (Figure 2E & 2F). Co-localization of SH3PXD2B
with cortactin was evident in 100% of cells that developed
membrane ruffles or lamellipodia in response to EGF stimulation.
To corroborate co-localization of SH3PXD2B with components
of the actin cytoskeleton, we examined its potential co-localization
with actin filaments in EGF-treated Cos-7 cells. For this set of
experiments, SH3PXD2B was tagged with a C-terminal V5
epitope and the construct encoding the fusion protein was
transfected into Cos-7 cells. Western blots of cell extracts derived
from the transfected cells contained a single band reacting with the
V5-specific antibody. The molecular weight of the expressed V5-
fusion protein was found to be identical to that of SH3PXD2B
(Figure 2G top panel) indicating that the protein was full-length
and unprocessed. To assess the extent of over-expression the same
blots were stripped and re-probed with an SH3PXD2B-specific
antibody (Figure 2G middle panel) which labeled the same
band in addition to the less prominent, endogenously expressed
SH3PXD2B. Similar to endogenously expressed SH3PXD2B, the
V5-epitope tagged fusion protein localized to membrane ruffles
where it co-localized with polymerized actin (Figure 2K–M). Co-
localization of V5-SH3PXD2B with actin was observed in 100%
of cells that developed membrane ruffles or lamellipodia. Co-
localization of endogenous SH3PXD2B with cortactin was also
evident in primary cells e. g. in lamellipodia at the leading edge
formed by polarized, migrating monocyte-derived macrophages
(Figure 3A–C) or HUVECs (Figure 3D–F).
Because cortactin is one of the podosome markers, we also
tested its co-localization with SH3PXD2B in Src-induced podo-
somes. To this end, we used a modified Rat-1 cell line, LA29ts,
that carries a temperature sensitive mutant form of Src [34,35,36].
In LA29ts cells, at the nonpermissive temperature (39.5uC), Src is
in an inactive conformation which is rapidly converted to the
active conformation when cells are cultured at the permissive
temperature (34.5uC). As predicted, activation of Src induces the
appearance of podosomes (Figure 3J–L.). Importantly,
SH3PXD2B primarily localized to the cytosol in LA29ts cells
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transfected with the full-length SH3PXD2B-EGFP construct when
they were kept at the nonpermissive temperature, (Figure 3G). By
contrast, when cells were grown at the permissive temperature, as
expected, SH3PXD2B localized to the forming rosettes of
podosomes (Figure 3J). To visualize podosomes and other
membrane structures, slides were counterstained with a cortac-
tin-specific antibody. Merging of the confocal images revealed co-
localization of SH3PXD2B and cortactin in Src-induced podo-
somes (Figure 3L), which was not observed in the absence of
active Src at the nonpermissive temperature (Figure 3I). Co-
localization between SH3PXD2B and cortactin at the permissive
temperature was evident in over 95% of the cells (Figure 3M).
Functional activity of cortactin- and SH3PXD2B-rich structures
visually identified as podosomes were further analyzed in standard
gelatin-degradation assays. As shown in Figure S1, gelatinase
activity was readily detectable at the permissive temperature
suggesting that the developing podosomes were functionally active.
Taken together, SH3PXD2B closely follows the pattern of
cortactin’s intracellular movement into multiple actin-based
membrane structures including EGF-induced membrane ruffles
and lamellipodia or Src-induced podosomes, suggesting that
SH3PXD2B together with cortactin may function as a general
regulator of the actin cytoskeleton in various mammalian cells.
SH3PXD2B associates with cortactin and Src
Several key regulators of the actin cytoskeleton including
SH3PXD2B, cortactin, paxillin are phosphorylated by Src. To
gain further insight into SH3PXD2B function we used co-
immuno-precipitation to identify SH3PXD2B-associated phos-
phoproteins that are phosphorylated by Src [14,15,26,37]. 293T
cells were transiently transfected with the construct encoding a C-
terminal V5-tagged full-length SH3PXD2B protein alone or in
combination with a construct expressing Src (Figure 4A).
Transfected cells were lysed 48 hours after transfection and V5-
SH3PXD2B was immunoprecipitated with a V5-specific antibody.
Western blotting with a phosphotyrosine-specific antibody re-
vealed three dominant bands with molecular weights of 120 kD,
80 kD and 60 kD (Figure 4A top panel). Phosphorylation
requires at least a transient interaction between the kinase and its
substrate; thus, we tested whether SH3PXD2B and Src form a
complex. We found that Src was readily precipitated from cell
extracts prepared from cells co-transfected with V5-SH3PXD2B
and Src (Figure 4A panel Src). Src was absent in immunopre-
cipitates obtained from samples transfected with Src or V5-
SH3PXD2B alone. The 120 kD and the 60 kD proteins in
Figure 4A were SH3PXD2B and Src, respectively, as judged by
Figure 1. Expression of SH3PXD2B in various human cell lines and primary cells. (A) Expression of the SH3PXD2B protein in various
transformed cell lines (left panel), macrophages and HUVEC (right panel). SH3PXD2B was detected by the affinity purified antibody described in
Materials and Methods. Actin was used as a loading control. (B–D) Intracellular localization of SH3PXD2B. SH3PXD2B protein in HeLa cells (B), in
HUVECs (C) and in primary human macrophages (D) was visualized by immunofluorescence. Cells were grown on coverslips and processed as
detailed in Materials and Methods. Bars indicate 20 mm.
doi:10.1371/journal.pone.0023653.g001
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stripping and re-probing the anti-pY blots with the corresponding
specific antibodies (not shown).
The rapid cellular redistribution of SH3PXD2B in Src-
transformed Rat-1 cells, together with its co-localization with
cortactin in multiple cell types prompted us to examine potential
association of SH3PXD2B with cortactin. In the above described
experimental system V5 epitope tagged SH3PXD2B protein co-
precipitated cortactin from lysates of 293T cells (Figure 4B).
Figure 2. Epidermal growth factor receptor activation induces the co-localization of SH3PXD2B with cortactin and F-actin in
membrane ruffles and lamellipodia. Serum starved cells were left untreated (A–C and H–J) or treated with 100 ng/ml EGF (D–F & K–M) for 10
minutes. Cells were then fixed and processed for immunofluorescence. Endogenous expression of SH3PXD2B and cortactin in HeLa cells (A–F) were
detected using SH3PXD2B-specific rabbit polyclonal or cortactin-specific mouse monoclonal antibodies. Cellular localization of SH3PXD2B in Cos7
cells transfected with a construct encoding an SH3PXD2B fusion protein carrying a C-terminal V5 epitope tag (H–M) was visualized using a mouse
anti-V5 monoclonal antibody and anti-mouse Alexa488 (green). Filamentous actin (F-actin) was stained with Alexa568-labeled phalloidin. Bars
indicate 20 mm. Efficiency of SH3PXD2B-V5 overexpression was analyzed by western blotting (G).
doi:10.1371/journal.pone.0023653.g002
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Figure 3. Co-localization of SH3PXD2B with cortactin in HUVEC, macrophages and LA29ts fibroblasts. Human monocyte-derived
macrophages (A–C), HUVEC (D–F) were stained as described for Figure 2A–F. (G–L) Rat-1 LA29 fibroblast cells carrying a temperature sensitive
mutant form of Src were grown on coverslips and transfected with an SH3PXD2B-EGFP construct. Cultures were kept at the nonpermissive
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Furthermore, 80 kD phosphoprotein in Figure 4A was identified
as phosphorylated cortactin by re-probing the phospho-protein
blots with an anti-cortactin antibody (not shown). Although
phosphorylated forms of both SH3PXD2B and cortactin were
present in the complex (Figure 4A), the SH3PXD2B/cortactin
complex was also found without Src transfection suggesting that
complex formation may be independent of tyrosine phosphoryla-
tion (Figure 4B). In the converse experiments we used GST-
tagged cortactin to precipitate SH3PXD2B from lysates of 293T
cells in which SH3PXD2B was transfected or endogenously
expressed. As shown in Figure 4C (top panel), SH3PXD2B was
precipitated by the GST-cortactin from cell extracts containing
endogenous or elevated levels of SH3PXD2B. In further pull-
down experiments we localized the site of interaction to the C-
terminal of cortactin corresponding to amino acids 336–542
(Figure 4C middle and bottom panels). The interacting C-
terminal region includes the Calpain cleavage site, the proline-rich
region with numerous tyrosine and serine phosphorylation sites
and the SH3-domain of cortactin, partaking in protein interacions
with chief regulators of the cytoskeleton [20,21,38]. Because the
SH3-domain of cortactin seemed to be good candidate for
SH3PXD2B binding we assessed the binding of the C-terminal-
cortactin-GST fusion construct with the W525K substitution.
Changing the conserved tryptophan residue to lysine is known to
abolish binding to canonical SH3-binding sites in various SH3-
domains[39,40]. As shown in Figure 4C (bottom panel), the
GST-cortactin[336–542(W525K)] protein failed to precipitate
SH3PXD2B suggesting that their interaction required an intact
SH3-domain on cortactin.
Taken together, we identified Src and cortactin as parts of
complexes containing SH3PXD2B and we presented data
suggesting that cortactin binds to an SH3PXD2B-containing
complex through its SH3 domain.
The PX-domain SH3PXD2B binds PtdIns lipids.
Binding of the PX-domain to specific membrane lipids is
believed to contribute to the appropriate cellular localization of
PX-SH3-domain proteins [41]. Hence, we examined the specific-
ity of the PX-domain of SH3PXD2B towards various PtdIns lipids
in a protein-lipid overlay assay. As shown in Figure 5A, a
bacterially expressed GST-PX-domain fusion protein specifically
bound to phosphorylated forms of phosphatidylinositol (PtdIns)
however, interaction with phosphatidic acid (PA) was also
detected. These binding characteristics were reminiscent to the
PX-domains of FISH/Tks5 and p47phox [32,42,43]. In addition to
binding all three PtdIns-monophosphates, -diphosphates, binding
to PtdIns (3,4,5)P3 triphosphate was readily detected. Interestingly,
interaction with PtdIns(3,4)P2 was rather weak compared to that of
PtdIns(3,5)P2 (Figure 5A). This finding is in line with those by
Hishida et al. [29], showing strong binding of PtdIns(3,5)P2 but not
PtdIns(3,4)P2 to the PX-domain of murine SH3PXD2B. Next we
changed the Arginine residue at position 43 to Glutamine (R43Q).
Changing the homologous Arginine residue in p47phox and FISH/
Tks5 eliminated binding to both PtdIns(3)P and PA [32,42,43]. As
shown in Figure 5B the R43Q substitution abolished binding of
the PX-domain to immobilized membrane lipids. To further
corroborate these findings we generated liposomes of Phosphati-
dylcholine and PtdIns(3)P and incubated them with the GST-
fusion protein containing the wild-type or the R43Q mutant
SH3PXD2B PX-domain. As shown in Figure 5C, the wild-type
PX-domain is predominantly found in the liposome fraction
(pellet), while the R43Q mutant was only slightly enriched in the
pellet.
Abram et al. suggested that the PX-domain is necessary and
sufficient to drive podosomal localization of FISH/Tks5 in Src-
transformed NIH3T3 cells [32]. Furthermore, Oikawa et al.
demonstrated the importance of binding to PtdIns(3,4)P2 lipids by
the PX-domain in this process [6]. We reasoned that a functional
PX-domain should be essential for the proper re-localization of
SH3PXD2B into membrane ruffles in EGF-stimulated cells. We
introduced the R43Q substitution into the full-length protein and
compared the cellular localization of the transfected full-length
SH3PXD2B-V5 and the SH3PXD2B-V5(R43Q) fusion proteins
in response to EGF stimulation. Interestingly, similar to its wild-
type counterpart, the R43Q mutant protein localized to EGF-
induced membrane ruffles, suggesting that a functional PX-
domain is not essential for correct cellular localization of
SH3PXD2B. (compare Figure 5D & 5G with 2H). Further-
more, co-localization of SH3PXD2B with polymerized actin was
equally prominent (compare Figure 5F & 5I). Together these
experiments suggested that phospholipid binding of the
SH3PXD2B PX-domain does not play a major role in directing
SH3PXD2B to lamellipodia or membrane ruffles.
Development of lamellipodia and efficient cell spreading
is impaired in the absence of SH3PXD2B
Because SH3PXD2B co-localized with cortactin in EGF-
induced membrane ruffles and lamellipodia, we examined whether
SH3PXD2B plays an active role in the organization of these
structures.
To test this hypothesis, SH3PXD2B expression in HeLa cells
was silenced by transient transfection of specific siRNAs (si2, si3)
targeting different regions of the transcript. The efficiency of gene
silencing exceeded 80% in all experiments typically approaching
90–95% (Figure 6A). Stimulation of HeLa cells with EGF
resulted in rapid development of membrane ruffles in cells
transfected with control siRNA (shown by white arrows in
Figure 6B & 6D). By contrast, in cells transfected with
SH3PXD2B-specific siRNA formation of membrane ruffles and
lamellipodia was strongly reduced (Figure 6C & E). The
frequency of membrane ruffling was determined by evaluating a
minimum of 100 cells for each cell population in four independent
experiments (Figure 6F).
In a second set of experiments we created stable HeLa clones
expressing SH3PXD2B-specific small heteroduplex RNAs
(shRNA) or control shRNA (with target sequences identical with
si3 and si3c) from a vector carrying a puromycin resistance
cassette. After antibiotic selection cell lines with no SH3PXD2B
expression (Clones 1 and 2) and with normal SH3PXD2B
expression (Clones 3 and 4) were studied further (Figure 6G).
When stimulated with EGF, cortactin translocated rapidly into
membrane ruffles and lamellipodia in control cells (indicated by
white arrows in Figure 6J & 6K), while translocation of cortactin
in cells with diminished SH3PXD2B content was less prominent
temperature (39.5uC) for 24 hours. Next, half of the cells were grown further at the nonpermissive temperature until the end of the experiment (G–I).
The rest of the cells were cultured at the permissive temperature (34.5uC) overnight (J–L). Coverslips were prepared for immunfuorescence as
described in Materials and Methods. Cortactin and SH3PXD2B were visualized as described in the legend for Figure 2. Bars represent 20 mm. Co-
localization between SH3PXD2B and cortactin was observed in over 90% of the cells grown at the permissive temperature (M). Over 100 cells were
evaluated for each independent experiment. Error bars represent the Standard Error of the Mean, SEM. ***: p,0.001, n = 3.
doi:10.1371/journal.pone.0023653.g003
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Figure 4. SH3PXD2B associates with Src and cortactin. (A & B) 293T cells were transfected with constructs expressing full-length SH3PXD2B
carrying a C-terminal V5 epitope tag, Src or both. 48 hours past transfection cells were lysed and SH3PXD2B was precipitated using a V5-specific
antibody. Immunoprecipitated proteins were blotted onto nitrocellulose membranes and detected with the indicated specific antibodies. The 52 kD-
bands present in panel A. correspond to the heavy chain of the antibody used to precipitateV5-tagged SH3PXD2B. (C): In GST pull-down experiments
recombinant GST or a GST-cortactin fusion protein were precipitated with glutathion-agarose beads from 293T cell extracts transfected (+) or not (2)
SH3PXD2B Regulates Lamellipodia and Cell Spreading
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(Figure 6H & 6I). Furthermore, we observed that 90–95% of the
cells with normal SH3PXD2B expression generated lamellipodia
exceeding 10 mm (Figure 6J & 6K) while such lamellipodia in
cells with decreased SH3PXD2B content was only sporadically
observed (Figure 6H & 6I).
The lack of SH3PXD2B expression in many non-adherent cell
lines and primary cells (e.g. lymphocytes or unstimulated
monocytes) and its association with the actin cytoskeleton
suggested that SH3PXD2B may play a role in cell adhesion to
extracellular matrices and/or cell spreading. To examine the effect
of SH3PXD2B on spreading of transformed cell lines we used the
previously described HeLa lines in which SH3PXD2B expression
was inhibited by constitutively expressed specific shRNA.
SH3PXD2B-negative or control cells were placed on fibronec-
tin-coated coverslips, allowed to attach and spread for various
times including 30 minutes, one hour or 12 hours. Cells were
visualized by actin filament staining. Cell sizes were quantified by
image analysis of at least 200 cells on each image. We found that
Figure 5. Characterization of the lipid-bindig domain of SH3PXD2B. (A and B) The lipid specificity of the PX-domain of SH3PXD2B was
tested in protein-lipid overlay assay experiments using a recombinant GST fusion protein that contained the first 130 amino acid region of SH3PXD2B
(panel A, PX-GST) or its derivative containing the R43Q substitution within the PX-domain (panel B, PX(R43Q). Layout of the PIP strip was the
following: 1. Lysophosphatidic acid 2. Lyso-phosphatidylcholine 3. Phosphatidylinositol (PtdIns) 4. PtdIns(3)P 5. PtdIns(4)P 6. PtdIns(5)P 7.
Phosphatidylethanolamine 8. Phosphatidylcholine 9. Sphingosine 1-phosphate 10. PtdIns (3,4)P2 11. PtdIns(3,5)P2 12. PtdIns(4,5)P2 13.
PtdIns(3,4,5)P3 14. Phosphatidic acid 15. Phosphatidylserine 16. Blank. (C) Liposomes containing Phosphatidylcholine and PtdIns(3)P were mixed
with recombinant PX-GST or PX(R43Q)-GST and centrifuged at at 80000 g for 20 minutes. Pellet and supernatant were separated, boiled and then
subjected to SDS- polyacrylamide gel electrophoresis and western blotting as described in Materials and Methods. Blots were developed with a GST-
specific antibody (top panels). Distribution of the PX-GST proteins between the liposome (pellet) and the aqueous phase (supernatant) was
determined by densitometry (bottom panel). (D–I) Constructs expressing wild-type SH3PXD2B-V5 [SH3PXD2B-V5(WT)] or the SH3PXD2B-V5 with the
R43Q amino acid substitution [SH3PXD2B-V5(R43Q)] were transfected into COS-7 cells (Panels D–F and G–I, respectively). 24 hours past transfection
cells were serum depleted and activated with EGF as described for Figure 2. Actin and SH3PXD2B-V5 were visualized as described in the legends for
Figure 2H–M. Bars represent 20 mm.
doi:10.1371/journal.pone.0023653.g005
with SH3PXD2B (top panel). In similar pull-down experiments GST- fusion proteins representing the N-terminal 334 amino acid region (Cort (1–334))
or the C-terminal region (Cort (336-542)) or its substituent (Cort (336–542(W525K)) were precipitated from lysates of 293T cells (bottom panel).
SH3PXD2B was detected by western blotting. GST-proteins (30% of the amounts used in precipitation reactions) are visualized by Coomassie staining
(middle panel) Cort: cortactin.
doi:10.1371/journal.pone.0023653.g004
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Figure 6. SH3PXD2B is essential for generation of membrane ruffles and lamellipodia. HeLa cells were grown on coverslips at
subconfluent cell densities. Cells were transfected with double stranded control siRNA oligonucleotides (si2c and si3c) or siRNAs specific for
SH3PXD2B (si2 and si3). (A) SH3PXD2B levels in cell lysates on the day of the functional assays were determined by western blot analysis. (B–E) At day
2 serum-starved cells were stimulated with EGF, fixed and visualized by phase contrast microscopy. White arrows show membrane ruffles and
lamellipodia. (F) EGF-induced ruffling in cells transfected with the indicated siRNA-s were quantified at 10 minutes following activation. Percentages
of cells with (columns shaded light grey) or without the characteristic membrane ruffling (columns shaded dark grey) are depicted. 100 cells were
evaluated for each independent experiment (n = 4). Error bars represent the Standard Error of the Mean, SEM. ***: p,0.001, **: p,0.005. (G)
Expression levels of SH3PXD2B in independent HeLa clones stably expressing SH3PXD2B-specific shRNA (clone 1 and clone 2.) or in two controls
(clone 3 and clone 4). EGF-stimulated HeLa cell lines with diminished SH3PXD2B expression (H & I) or with normal SH3PXD2B expression (J & K) were
stained for cortactin as described above. White arrows indicate lamellipodia rich in cortactin. Bars represent 20 mm.
doi:10.1371/journal.pone.0023653.g006
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SH3PXD2B negative clones (clones 1 and 2 in Figure 7A) spread
poorly on fibronectin compared to clones expressing SH3PXD2B
(clones 3 and 4 in Figure 7A). A consistent, approximately 25%
reduction in the average cell size is apparent even by visual
inspection (Figure 7B–E).
Together, these experiments demonstrate that SH3PXD2B is
one of the key components of the molecular assemblies regulating
the development of actin-based membrane structures essential for
cellular attachment and spreading.
Discussion
Development of membrane protrusions such as lamellipodia
and membrane ruffles requires the concerted action of several
signaling proteins and phospholipids [44,45]. In this paper we
report that SH3PXD2B is an important component of the
signaling machinery regulating the formation of these membrane
structures. SH3PXD2B is a recently described homolog of FISH/
Tks5, a Src substrate required for the organization of Src-induced
podosomes [7]. Both proteins are characterized by the presence of
an N-terminal PX-domain, followed by four SH3 domains in
SH3PXD2B, and five SH3 domains in FISH/Tks5. FISH/Tks5
was described to localize to podosomes of Src-transformed
fibroblasts [32]. An active involvement of FISH/Tks5 in the
organization of podosomes was also demonstrated by Seals et al.
showing that siRNA mediated downregulation of FISH/Tks5 in
Src-transformed cells inhibited podosome formation and reduced
invasiveness [7]. Podosomal localization [26,31] of SH3PXD2B
and its role in controlling matrix degradation by Src-induced
podosomes of murine embryo fibroblasts have also been reported.
Data concerning the characteristics of the human orthologue of
SH3PXD2B are sporadic, and little is known about the role this
novel adaptor protein may play in the organization of other actin-
based membrane organelles.
Based on its association with podosomes, it is not unexpected
that we found SH3PXD2B highly expressed in multiple tumor-
derived cell lines (Figure 1A). Analysis of the subcellular
localization of the protein in unstimulated HeLa and Cos-7 cells
revealed an abundant cytoplasmic staining. In the presence of
epidermal growth factor SH3PXD2B associated with EGF-
induced membrane ruffles and lamellipodia (Figure 2A–F).
We also pursued to map the structural requirements for the
translocation of SH3PXD2B in response to EGF. Based on the
presence of the N-terminal PX-domain we hypothesized that a
lipid-protein interaction might be the driving force behind
SH3PXD2B translocation. PX-domains are lipid-binding mod-
ules, present in several proteins involved in signaling and
trafficking [41] binding to phosphorylated PtdIns. According to
our experiments, the PX-domain of SH3PXD2B binds to all three
PtdIns-monophosphates, -diphosphates, and PtdIns(3,4,5)P3 de-
tected by using purified recombinant GST-PX-domain in protein-
lipid overlay assay experiments. Interestingly, a relatively strong
binding of PtdIns(3,5)P2 compared to PtdIns(3,4)P2 was detected
in compliance with the data reported by Hishida et al. [29], and to
some extent contradicting the results of the Courtneidge group
[26] showing strong binding to PtdIns(3,4)P2 but not to
PtdIns(3,5)P2. Importantly, binding to PI(3,4,5)P3 was also
detected which was not detected by either group using the murine
protein.
Next we examined the EGF-induced membrane translocation
of the full-length protein which carried a deleterious mutation in
the PX-domain. Mutation of a conserved residue (R43) located
within the PX-domain had no effect on the localization of the full-
length protein, suggesting that phospholipid-protein interaction is
not the major driving force targeting SH3PXD2B to actin-rich
membrane protrusions (Figure 5D–I). This finding challenges the
generally accepted idea that the PX-domain and its binding
affinity to particular phosphatidylinositol phosphates targets PX-
domain containing proteins into appropriate membrane compart-
ments. Thus, in the case of SH3PXD2B, protein interactions may
play a dominant role in appropriate cellular targeting. In line with
this, SH3PXD2B is not the only PX/SH3-domain containing
protein where subcellular targeting is under the control of protein
interactions. PI3-kinase dependent indirect membrane targeting of
p47phox via interaction with moezin was suggested by Zhan et al.
[46,47]. Although we found binding of phosphorylated PtdIns
dispensable for the translocation of SH3PXD2B into lamellipodia,
lipid binding by the PX-domain still could be responsible for the
stabilization of the protein in the above structures. In line with this,
upon activation by various chemoattractants, phosphoinositides
including PtdIns(3,4,5)P3 are enriched in lamellipodia formed at
the leading edge of migrating cells [9]. This latter finding also
Figure 7. In the absence of SH3PXD2B cell spreading is
impaired. (A–E) The HeLa clones described in Figure 6 were seeded
onto fibronectin-coated coverslips, fixed and permeabilized after 30
minutes and stained with TRITC-Phalloidin. Cell surface area was
calculated based on images of over 200 cells using the ImageJ 1.38x
software. Average size of the cells for two SH3PXD2B-negative (clones 1
and 2) and two control cell lines (clones 3 and 4) is plotted (A). Panels B-
E show representative images of poorly spread (B and C) and well
spread (D and E) HeLa cells. Error bars represent the Standard Error of
the Mean, SEM. ***: p,0.001, n = 6 Bar represents 20 mm.
doi:10.1371/journal.pone.0023653.g007
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underlines the potential significance of PtdIns(3.4.5)P3 binding by
the PX-domain.
In our work several observations indicate that the presence of
SH3PXD2B in lamellipodia and membrane ruffles and its co-
localization with cortactin in these structures is not accidental;
rather, SH3PXD2B is requisite for the formation of these
structures. Elimination of SH3PXD2B in HeLa cells by RNA
interference strongly reduced EGF-induced lamellipodia forma-
tion and also inhibited the characteristic membrane localization of
cortactin (Figure 6H–K). When SH3PXD2B expression in HeLa
cells was inhibited, the cells spread less efficiently on fibronectin
coated surfaces indicating a substantial role of SH3PXD2B in this
process (Figure 7A–E).
These observations indicate that the role of SH3PXD2B is not
restricted to the regulation of podosome formation. Our
experiments revealed protein-protein interactions that might be
crucial in SH3PXD2B action. We showed that SH3PXD2B co-
localized with cortactin in EGF-induced membrane ruffles and
was part of a complex containing cortactin, a well-known Src-
substrate with a central role in the organization of the cortical
actin cytoskeleton (Figure 2D–F & 4B). Cortactin is a scaffold
protein, which brings together several proteins at the sites of actin
polymerization [20,48]. The N-terminal part of cortactin contains
an N-terminal acidic region that binds to the Arp 2/3 complex
and a repeat region with sites for F-actin binding. The C-terminal
part contains a proline-rich region with Src-phosphorylation sites
and an SH3 domain. This region of cortactin has been reported to
bind several proteins, including WASP, dynamin 2 and WIP [20].
Although we cannot exclude that association of SH3PXD2B
with cortactin requires other proteins, it is tempting that the SH3-
domain of cortactin binds to one of the proline-rich regions on
SH3PXD2B. Indeed, in pull-down experiments we localized the
region required for the interaction between SH3PXD2B and
cortactin to the C-terminal part (amino acids 336–542) of cortactin
(Figure 4C) and showed that this interaction required the
presence of an intact SH3-domain on cortactin (Figure 4C
bottom panel). Importantly, the SH3-domain of cortactin has
also been shown to interact with FISH/Tks5 [49]. Surprisingly,
association of SH3PXD2B with cortactin did not require tyrosine-
phosphorylation of either protein (compare Figure 4B with 4C).
We speculate that, similar to p47phox, induction of the functionally
active conformation of SH3PXD2B may require phosphorylation
of serine residues of SH3PXD2B, cortactin or both. In support of
this, EGF-stimulation of tumor cells leads to phosphorylation of
cortactin at serine residues 405 and 418 inducing a characteristic
shift in cortactin electrophoretic mobility from 80 kDa to 85 kDa
[50,51]. Phosphorylation of these serine residues by ERK1/2 has
recently been shown to be requisite for efficient tumor cell motility,
adhesion and lamellipodia persistence [52]. It is tempting to
speculate that the phosphorylation by ERKs or other kinases on
appropriate serine residues may be required for the translocation
of SH3PXD2B to the membrane. By the interaction of
SH3PXD2B with cortactin, a complex interface of five SH3
domains, two proline rich regions, at least seven tyrosine and
multiple serine residues may be formed representing a binding
surface with exceptional complexity. Association of SH3PXD2B
with cortactin-containing complexes brings SH3PXD2B to close
proximity with cortactin-associated proteins, many of which may
prove to be regulated by SH3PXD2B.
Although detailed description of the molecular scaffold of
SH3PXD2B and cortactin is yet ahead of us, we identified
SH3PXD2B as a novel interacting partner of Src and cortactin.
Via modulating the cellular localization or the activity of cortactin
SH3PXD2B may be a key regulator of cellular attachment and
migration during the course of development, in the process of the
normal immune response, or in migration and attachment of
transformed cells. We think that our findings broaden our view on
the multiple developmental defects observed in the absence of
SH3PXD2B both in humans and mice [30,31].
Materials and Methods
Cells and antibodies
Human umbilical vein endothelial cells (HUVECs) were
purchased from Cascade Biologics. Human monocytes were
obtained from leukocyte-enriched buffy coats obtained from healthy
volunteer blood donors drawn at the Regional Blood Center of
Hungarian National Blood Transfusion Service (Debrecen, Hun-
gary) in accordance with the written approval of the Director of the
National Blood Transfusion Service and the Regional and
Institutional Ethics Committee of the University of Debrecen,
Medical and Health Science Center (Debrecen, Hungary). Written
informed consent was obtained from the donors prior to blood
donation, and their data were processed and stored according to the
principles expressed in the Declaration of Helsinki. Human
monocytes were isolated as described previously [53]. Macrophages
were differentiated in the presence of 50 ng/ml macrophage
colony-stimulating factor (M-CSF, Peprotech). The Rat-1 LA29ts
cells were a generous gift of Margaret Frame [36]. The A2058
melanoma cell line was generously shared with us by Margit Balazs
[54]. All other cell lines including HeLa, 293T, COS7, Jurkat,
REH, THP1 and TF1 cells, were obtained from American Type
Culture Collection (ATCC) and were maintained according to the
distributor’s instructions. Media for the maintenance of TF1 cells
were supplemented with 5 ng/ml granulocyte-macrophage colony-
stimulating factor (GM-CSF, Peprotech). The following antibodies
were used in this study: anti-actin (SIGMA), antiphospho-tyrosine
(4G10, PT66, Sigma) and anti-cortactin (Upstate), anti-V5 (AbD
Serotec), anti-cSrc (SantaCruz).
DNA constructs
To create V5-tagged SH3PXD2B construct the full-length
SH3PXD2B coding sequence was cloned into a pcDNA3.1/
TOPO-V5-His plasmid (Invitrogen). To create fluorescent protein
tagged SH3PXD2B construct the full-length SH3PXD2B coding
sequence was cloned into the pEGFP-N1 vector (Clontech). An
EGFP-tagged SH3PXD2B PX-domain was created by cloning
SH3PXD2B cDNA encoding the first 130 amino acids of the
protein into pEGFP-N1 vector. For the production of a
SH3PXD2B PX-domain-GST fusion protein, the same cDNA
was cloned into a pGEX4T1 plasmid. The R43Q, single amino acid
change was introduced into the full-length SH3PXD2B-V5
construct using the Stratagene’s Quikchange site directed muta-
genesis kit following the manufacturer’s instructions. Constructs
were verified by sequencing. To generate constructs encoding
various segments of GST-cortactin fusion proteins the full-length
cortactin (mouse cDNA) was amplified by PCR and subcloned into
BamH1/EcoRI sites of pGEX-4T-1 vector (GE Healthcare). cDNAs
corresponding to the N-terminal part (amino acids 1–334) and C-
terminal part (amino acids 336–542) of cortactin were also amplified
by PCR and subcloned into EcoRI/XhoI sites of pGEX-4T-1
plasmid. The Src construct was a generous gift of Julian Downward
(Cancer Research UK, London) and was used earlier [55].
Production and affinity purification of SH3PXD2B-specific
antibody
Polyclonal SH3PXD2B-specific antibody was purified from
rabbit serum following intra-cutaneous injections of GST-
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SH3PXD2B (amino acids 23–430) fusion protein into rabbits.
SH3PXD2B-specific antibodies were purified from the rabbit sera
in two steps. First, GST-specific antibodies were depleted from the
immune serum using recombinant GST protein coupled to
glutathione sepharose beads followed by an affinity purification
step using Affigel 10 beads (BioRad Laboratories) loaded with the
antigen.
Transient transfection, immunoprecipitation, western
blotting
293T cells were transfected by the standard calcium-phosphate
method. Cells were seeded at the density of 3x106 cells on 100 mm
plates. Next day, cells were transfected with 20 mg SH3PXD2B-
V5 and 5 mg c-Src either alone or in combination. To equalize the
amount of DNA each transfection reaction was supplemented with
the appropriate empty vectors. 48 hours post-transfection cells
were lysed in RIPA buffer (1% Triton X-100, 0.5% Deoxy-cholate
and 0.1% SDS) containing phosphatase inhibitor mix (Sigma),
protease inhibitors: Aprotinin, Leupeptin, Pepstatin, Bestatin
(20 ug/ml each) and 1 mM PMSF. Lysates cleared from detergent
insoluble material by centrifugation at 15,0006 g for 10 min at
4uC, were incubated overnight at 4 0C with 4 mg anti-V5 antibody
(AbD, Serotec) and 30 ml of ImmunoPure Immobilized Protein G
beads (Pierce) or with glutathion-agarose beads (GST pulldown
experiments). Immunoprecipitates were washed four times with
ice-cold 50 mM HEPES buffer, pH 7.4, containing 150 mM
NaCl, 0.2% Triton X-100. Precipitated complexes were subjected
to SDS-PAGE and transferred to polyvinylidine difluoride
membranes (Immobilon-P, Millipore). Membranes were blocked
with 3% BSA (Sigma), incubated with the indicated primary
antibodies and horseradish peroxidase-conjugated secondary
antibodies (Amersham), and developed using enhanced chemilu-
minescence (ECL West Pico, Pierce). For precipitation with GST
fusion proteins 5 mg of the specified GST-cortactin proteins were
used as non-covalently bound adducts to glutathione-agarose
beads. Separation of bound proteins and immunoblotting were
performed as described previously [56].
Downregulation of SH3PXD2B expression in HeLa cells
by RNA interference
For transient transfection experiments SH3PXD2B-specific
StealthH siRNAs and ‘‘minimally’’ changed, control siRNAs were
obtained from Invitrogen. The target sequences on SH3PXD2B
mRNA were the followings: GCCTGATACCAATTGATGAA-
TACTG (Si2-SH3PXD2B), GCTGGTGGTACATTCAGATT-
GAAGA (Si3-SH3PXD2B). The control sequences were the
followings: GCCGGATACCAATTGATTAACATTG (Si2con-
trolSH3PXD2B) GCTAGTGGTACGTTCAGATTGGAAA
(Si3controlSH3PXD2B). Nucleotides altered to obtain the control
oligonucleotides are underlined. Si2-SH3PXD2B targets exon 4
encoding part of the PX-domain, while Si3-SH3PXD2B targets
exon 13 located within the region encoding the third SH3-domain
of SH3PXD2B. siRNAs were transfected into Hela cells at
100 nM using the RNAiMax transfection reagent (Invitrogen).
Cells were routinely analyzed 48 hours after transfection. To
create HeLa cell lines stably expressing SH3PXD2B-specific
siRNAs we used the siSTRIKE system from Promega. The
double-stranded oligonucleotides representing the si3-SH3PXD2B
or si3control-SH3PXD2B target sequences together with sequenc-
es required to form the double-stranded loops of the shRNA were
cloned downstream of the U6 promoter region of the siSTRIKE-
Puro vector as suggested by the manufacturer. 106 cells were
transfected with siSTRIKE plasmid expressing SH3PXD2B-
specific siRNA (or mutant construct as a control) using Fugene 6
transfection reagent (Roche). 72 hours past transfection stable
transfectants were selected in the presence of 1 mg/ml puromycin
for 1 week. Next, single cell clones were isolated by limiting
dilution in the presence of 1 mg/ml puromycin. SH3PXD2B
expression was analyzed by PAGE and western blotting using the
affinity purified antibody. Immunoblots were developed with the
affinity-purified SH3PXD2B-specific antibody described above. b-
actin was used as a loading control. We have isolated 20
puromycin-resistant HeLa clones which were further studied.
Immunofluorescent labeling and confocal laser
microscopy
Cells grown on coverslips were fixed in 4% paraformaldehyde in
PBS then washed 5 times in PBS and incubated for 10 minutes in
PBS containing 100 mM glycine. Coverslips were washed 2 times in
PBS and permeabilized in PBS containing 1% BSA and 0.1%
Triton X-100 for 20 minutes at room temperature. After 1 hour
blocking in PBS containing 3% BSA cells were incubated with the
primary antibody in PBS plus 2% BSA, washed thoroughly 6 times
in PBS and incubated with the secondary antibody for 1 hour and
finally washed 6 times in PBS again. Coverslips were mounted using
Mowiol 4–88 antifade reagent (prepared from polyvinyl alcohol 4–
88, glycerol, H2O and Tris pH 8.5).
Confocal images were collected on an LSM510 laser scanning
confocal unit (Carl Zeiss) with a 6361.4 numerical aperture plan
Apochromat and a 4061.3 numerical aperture plan Neofluar
objective (Carl Zeiss). Excitation was with 25 mW argon laser
emitting 488 nm, and a 1.0 mW helium/neon laser emitting at
543 nm. Emissions were collected using a 500–530 nm band pass
filter to collect A488 and GFP and a 560 nm long pass filter to
collect A568 and RFP emission. Usually images from optical slices
of 1–2 mm thickness were acquired. Crosstalk between fluoro-
phores was negligible.
Gelatin degradation assay
Coverslips were coated with 1 mg/ml gelatin conjugated with
Oregon Green488 (Molecular Probes, G13186) dissolved in 2%
sucrose at 4uC for 20 minutes in the presence of glutaraldehyde. After
washing three-times in PBS coverslips were incubated with 5 mg/ml
NaBH4 (dissolved in PBS) at RT for 3minutes, washed again as above
and sterilized and dried using 70% ethanol. Rat-1 LA29 fibroblast
cells carrying a temperature sensitive mutant form of Src were grown
at the nonpermissive temperature for 24 hours then seeded onto
coverslips coated with the conjugated gelatin and incubated for 9 hrs
at either the nonpermissive or at the permissive temrerature.
Coverslips were prepared for immunfuorescence as described above.
Lipid binding assay
PIP strips were obtained from Invitrogen. Protein-lipid overlay
assay experiments were performed using SH3PXD2B PX(1–130)-
GST and GST fusion proteins following the manufacturer’s
protocol. Layout of the PIP strip was as follows: 1. Lysopho-
sphatidic acid 2.Lyso-phosphatidylcholine 3. Phosphatidylinositol
(PtdIns) 4. PtdIns(3)P 5. PtdIns(4)P 6. PtdIns(5)P 7. Phosphatidyl-
ethanolamine 8. Phosphatidyl-choline (PC) 9. Sphingosine 1-
phosphate 10. PtdIns (3,4)P2 11. PtdIns(3,5)P2 12. PtdIns(4,5)P2
13. PtdIns(3,4,5)P3 14. Phosphatidic acid 15. Phosphatidylserine
16. Blank.
Liposome binding assay
Two lipids, PC and PtdIns(3)P were dissolved in chloroform at
the concentration of 10 mg/ml and dried under nitrogen
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atmosphere. To prepare liposomes, in each experiment 100 mg
total lipid was rehydrated at room temperature in 50 ml 10 mM
HEPES, 140 mM NaCl, pH 7.4, followed by vortexing until the
mixture was homogeneously opalescent. The GST-fusion proteins
were centrifuged at 80000 g for 20 min to remove all aggregates.
One microliter of supernatant (containing approximately 1 mg
protein) was added to 50 mL of liposome solution. Binding was
performed at 37uC for 30 min on a laboratory rocker. The vesicles
were centrifuged at 80000 g for 20 min. Pellet and supernatant
were separated, boiled and then subjected to SDS-PAGE. The
protein was detected by western-blotting with a GST-specific
antibody. Densitometry on scanned Images was done using the
ImageJ 1.38x software.
Cell spreading on fibronectin
Glass coverslips were coated with fibronectin (20 mg/ml) at 4uC,
overnight and washed twice with PBS to remove any unbound
fibronectin. To block remaining binding sites, coverslips were then
incubated with 5% BSA. HeLa cells were plated onto 12 well
plates containing the fibronectin-coated coverslips and fixed by
4% paraformaldehyde at various time points after plating. Fixed
cells were permeabilized by 0.2% Triton X-100 in PBS for 5 min
followed by phalloidin staining (0.1 mg/ml TRITC-phalloidin in
PBS for 20 min). TRITC-phalloidin stained cells were photo-
graphed using a Nikon Eclipse E400 fluorescent microscope. At
least 200 cells from each slide were analyzed using the ImageJ
1.38x software (NIH, USA).
Supporting Information
Figure S1 Src activation induces the development of
functionally active podosomes in LA29ts cells. Rat-1 LA29
fibroblast cells carrying a temperature sensitive mutant form of Src
were cultured at the nonpermissive temperature (39.5uC) for 24
hours. Next, cells were seeded onto coverslips coated with
OregonGreen488-labeled gelatin and incubated for 9 hrs at the
nonpermissive (A–C) or at the permissive (D–F) temperature.
Cortactin was visualized as described in the legend for Figure 2.
White arrows point to areas where podosome structures still
overlap with degrading gelatin (orange color). Dark dot-shaped
areas represent previous attachment sites of podosomes where
gelatin had been degraded and podosomes detached as cells
moved on. Bar represents 20 mm.
(TIF)
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